| アブストラクト | As COVID-19 vaccinations begin, dermatologists must be aware of the cutaneous adverse events reported in the clinical trials, including injection site and hypersensitivity reactions, and emerging evidence of dermal filler injection reactions after vaccination. The filler reaction may represent the development of a delayed-type hypersensitivity in the setting of another immunologic trigger (i.e., the vaccine). After conducting a literature review of similar reactions, their pathophysiology, and management, we present a set of timely clinical considerations for counseling, prevention, and management of possible cutaneous sequelae of the COVID-19 vaccine. We encourage documentation of vaccine-related reactions to aid the safety data collection in the Vaccine Adverse Event Reporting System and the American Academy of Dermatology COVID-19 Registry. |
|---|
| ジャーナル名 | International journal of women's dermatology |
|---|
| Pubmed追加日 | 2021/1/19 |
|---|
| 投稿者 | Rice, Shauna M; Ferree, Sarah D; Mesinkovska, Natasha Atanaskova; Kourosh, Arianne Shadi |
|---|
| 組織名 | Massachusetts General Hospital, Department of Dermatology, Boston, MA, United;States.;Cambridge Health Alliance, Cambridge, MA, United States.;Harvard Medical School, Boston, MA, United States.;University of California Irvine, Department of Dermatology, Irvine, CA, United |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/33457487/ |
|---|
